INDIA – Tata 1mg Labs, India’s largest digital health platform, is gearing up to conduct about 10,000 Anemia tests free of charge targeting people in India, particularly women and children.
Tata 1mg Labs is rolling out a crucial campaign to raise Anemia awareness designed to offer vital health support to those in need across the country.
As part of the India-focused awareness campaign, Tata 1mg Labs has joined forces with multiple non-governmental organizations (NGOs) to promote the importance of early detection and seeking timely medical attention.
Tata 1mg Labs’ latest campaign aims to increase awareness and share comprehensive knowledge about Anemia and its symptoms and the benefits of early detection and intervention.
In a press statement, the Tata Group subsidiary said: “The Tata 1mg Labs Anemia Screening Campaign aims to build awareness about timely testing by conducting 10,000 free tests for women and children residing in underprivileged areas.”
This awareness campaign comes as part of JRD Tata’s birth anniversary celebrations, where Tata Group companies come together to celebrate the legacy of the visionary leader.
In 2021, Tata Digital, a wholly-owned subsidiary of the Tata Group, acquired a majority stake in 1mg, and the company was rebranded as Tata 1mg.
The Tata 1mg Labs’ anemia Awareness campaign is a heartfelt tribute to the values cherished by JRD Tata, and it epitomizes the group’s commitment to giving back to society.
As a tribute to JRD Tata’s unwavering commitment to a healthier nation, Tata 1mg Labs plans to conduct 10,000 free Anemia tests for women and children before the end of 2023.
Tata 1mg Labs will work closely with participating non-governmental organizations to ensure the success and reach of this life-transforming Anemia awareness campaign.
Through these partnerships, the Anemia screening tests will be conducted via a series of camps held over the next two quarters across multiple cities, bringing essential healthcare services closer to those in need.
Commenting on the disease burden, Gaurav Agarwal, Co-founder of Tata 1mg, noted: “Anemia has emerged as a critical health concern for our nation. The Anemia rate among women and children in India surpasses the global average.”
Anemia, a condition characterized by low hemoglobin levels, primarily caused by iron deficiency, poses a significant health challenge, leading to chronic weakness and fatigue.
In India, a staggering 57% of women aged 15-49 years are anemic, forming a substantial proportion of the global Anemia-affected population.
An alarming contributing factor to this issue is the lack of visibility of Anemia, especially among females.
Tata 1mg Labs aims to contribute to a healthier nation, aligning with its brand promise of making healthcare accessible, affordable, and understandable, with utmost dedication and care.
Expressing his thoughts about the latest campaign, Gaurav Agarwal outlined: “By conducting these screening tests for the more vulnerable population and providing them with holistic treatment and prevention, we hope to make a tangible impact on the lives of 10,000 people.”
This timely initiative comes as India’s Prime Minister Narendra Damodardas Modi officially launched the new Sickle Cell Anemia eradication mission.
As part of the new NSCAEM, Indian Prime Minister Modi unveiled a new health portal and national guidelines for the management of the genetic blood disease and different modules for its monitoring.
The latest guidelines are anticipated to support decision-makers in allocating appropriate funds to the health budget for the timely detection of Sickle cell Anemia, disease treatment, and prevention.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
